Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus

Annals of Saudi Medicine

Volumn 28, Issue 5, 2008, Pages 367-370

  Al Shoumer, Kamal A ^a,b   Al Asousi, Adnan A ^b   Doi, Suhail A ^a   Vasanthy, Bagavathy A ^b  

^a MUBARAK AL KABEER HOSPITAL   (Kuwait)

^b KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; ORAL ANTIDIABETIC AGENT; PROINSULIN; SOMATOMEDIN C; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARAB; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC DIET; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; BLOOD; CASE CONTROL STUDY; ETHNOLOGY; METABOLISM;

ADULT; ARABS; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; OBESITY; PROINSULIN; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 58249086294     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.5144/0256-4947.2008.367     Document Type: Article

References (41)

1. Boden G. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes. 1997;46:3-10.
2. Boden G. Pathogenesis of type 2 diabetes, insulin resistance. Endocrinol Metabo Clin North Am. 2001;30:801-815.
3. Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM. The role of lipids in the pathogenesis of muscle insulin resistance and β-cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes. 2001;Suppl 2:S189-S201.
4. Considine RV, Sinha MK, Heinman ML, et al. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
5. Sivitz WL, Walsh SA, Morgan DA, Thomas MJ, Haynes WG. Effects of leptin on insulin sensitivity in normal rats. Endocrinol. 1997;138:3395-3401.
6. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R. Wnters D, Boone T, Collins F. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995;208:540-543.
7. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389:374-377.
8. Kieffer TJ, Habener JF. The adipoinsular axis: effects of leptin on pancreatic β-cells. Am J Physiol. 2000;278:E1-E14.
9. Al-Shoumer KA, Vasanthy BK, Makhlouf HA, Al-Zaid MM. Leptin levels in Arabs with primary hyperthyroidism. Ann Saudi Med. 2000;20:113-118.
10. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. Leptin concentrations in diabetic and non-diabetic Mexican-Americans. Diabetes. 1996;45:822-824.
11. Guler S, Cakir B, Demirbas B, Gursony G, Serter R, Araf Y. Leptin concentrations are related to glycemic control, but do not change with short-term oral antidiabetic therapy in female patients with type 2 diabetes. Diabetes Obes Metab. 2000;2:313-316.
12. Schwartz MW, Prigeon RL, Kahn SE, et al. Evidence that plasma leptin and insulin levels are associated body adiposity via different mechanisms. Diabetes Care. 1997;20:1476-1481.
13. Mannucci E, Ognibene A, Cremasco F, et al. Glucagon-like peptide (GLP)-I and leptin concentrations in obese patients with type 2 diabetes mellitus. Diabet Med. 2000;17:713-719.
14. Ozata M, Gungor D, Turan M, et al. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentration in type II diabetes subjects. J Clin Endocrinol Metab. 2001;86:3659-3664.
15. Clement K, Lahlou N, Ruiz J, et al. Association of poorly controlled diabetes with low serum leptin level in morbid obesity. Int J Obes. 1997;21:556-561.
16. Roden M, Ludwig C, Nowotny P, et al. Relative hypoleptinemia in patients with type 1 and type 2 diabetes mellitus. Int J Obesity Relat Metab Disord. 2000;24:976-981.
17. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPD 20: Plasma leptin, obesity, and plasma insulin in type 2 diabetes subjects. J Clin Endocrinol Metab. 1997;82:654-657.
18. Havel PJ, Uriu-Hare JY, Liu T, et al Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol. 1998;274;R1482-R1491.
19. Sivitz WI, Walsh S, Morgan D, Donohoue P, Haynes W, Leibel RL. Plasma leptin in diabetic and insulin-treated diabetic and normal rats. Metab Clin Exp. 1998;47:584-591.
20. Soliman AT, Omar M, Assem NM, et al. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control. Metab Clin Exp. 2002;51:292-296.
21. Kirel B, Dogruel N, Korkmaz U, Kilic FS, Ozdamar K, Ucar B. Serum leptin levels in type 1 diabetes and obese children: relation to insulin levels. Clin Biochem. 2000;33:475-480.
22. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, Kern PA, Friedman JM. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1:1155-1161.
23. Horwitz D, Kuzuya H, Rubenstein AH. Circulating serum C-peptide. N Engl J Med. 1979;295:207-209.
24. Ruhl CE, Everhart JE. Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr. 2001;74(3):295-301.
25. Lindeberg S, Soderberg S, Ahren B, Olsson T. Large differences in serum leptin levels between nonwestemized and westernized populations: the Kitava study. J Intern Med. 2001;249(6):553-8.
26. Kalhan R, Puthawala K, Agarwal S, Amini SB, Kalhan SC. Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metab. 2001;50(10):1197-202.
27. Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD. Lean, non-diabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord. 2003;27(7):784-9.
28. Perry HM 3rd, Morley JE, Horowitz M, Kaiser FE, Miller DK, Wittert G. Body composition and age in African-American and Caucasian women: relationship to plasma leptin levels. Metab. 1997;46(12):1399-405.
29. Iputo JE, Robinson D, Mguni M. Serum leptin concentration in a rural African population. East Afr Med J. 2001;78(9):484-8.
30. Malmstrom R, Taskinen MR, Karonen SL, Ki-Jarvinen H. Insulin increases plasma leptin concentrations in normal subjects and patients with NIDDM. Diabetologia. 1996;39:993-996.
31. Schwartz MW, Prigeon RL, Kahn SE, Nicolson M, Moore J, Morawiecki A, Boyko EJ, Porte D Jr. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms. Diabetes Care. 1997;20:1476-1481.
32. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab. 1997;82:1293-1300.
33. McGregor GP, Desaga JF, Ehlenz K, Fischer A, Heese F, Hegele A, Lammer C, Peiser C, Lang RE. Radiommunological measurement of leptin in plasma of obese and diabetic human subjects. Endocrinol. 1996;137:1501-1504.
34. Haffner SM, Mykkanen L, Stern MP. Leptin concentrations in women in the San Antonio Heart Study: effect of menopausal status and postmenopausal hormone replacement therapy. Am J Epidemiol. 1997;146:581-585.
35. de Courten M, Zimmet P, Nudge A, Collins V, Nicolson M, Staten M, Dowse G, Alberti KG. Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med. 1997;14200-208.
36. Chessler SD, Fujimoto WY, Shofer JB, Boyko EJ, Weigle DS. Increased plasma leptin levels are associated with fat accumulation in Japanese Americans. Diabetes. 1998;47:239-243.
37. Al-Daghri A, Al-Rubean K, Bartlett WA, Al-Attas O, Jones AF, Kumar S. Serum leptin is elevated in Saudi Arabian patients with metabolic syndrome and coronary artery disease. Diabet Med. 2003;20:832-837.
38. Clement K, Lahlou N, Ruiz J, Hager J, Bougneres P, Basdevant A, Guy-Grand B, Froguel P. Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes. 1997;21:556-561.
39. Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH, Bogardus C. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med. 1997;3:238-240.
40. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationship in obese and nonobese humans. Diabetes 1996;45:695-698.
41. Ayub N, Khan SR, Syed F. Leptin levels in pre and post menopausal Pakistani Women. J Pak Med Assoc. 2006;56:3-5.